COVID-19 antibody treatment clinical trial paused over potential safety concern
Drugmaker Eli Lilly announced a temporary hold on its COVID-19 antibody therapy. The pause comes as a need for the treatment grows. A CDC report found that a 13-year-old girl infected 11 members of her family while on vacation. Adriana Diaz reports.